End-Stage Kidney Disease Interactive Decision Aid for the Elderly (myKIDNEY)

Sponsor
Duke-NUS Graduate Medical School (Other)
Overall Status
Recruiting
CT.gov ID
NCT05407896
Collaborator
Singapore General Hospital (Other), National University Hospital, Singapore (Other)
208
2
2
27
104
3.9

Study Details

Study Description

Brief Summary

Decision aids are highly recommended for decisions when there is no "right" treatment choice. The goal is to help patients choose a treatment that is consistent with their preferences and to minimize decisional conflict and regret. A case where there is no "right" treatment concerns the decision to undergo dialysis or supportive care (i.e., conservative management) for elderly (aged ≥70) patients with end-stage kidney disease. The investigators propose to develop an interactive web-based decision aid and test its effectiveness via a pre-post study design. This research aims to reduce decisional conflict for elderly ESKD patients and caregivers.

Condition or Disease Intervention/Treatment Phase
  • Other: myKIDNEY decision aid
N/A

Detailed Description

For patients aged 75 and above with comorbidities, the benefits of dialysis over kidney supportive care, which focuses on maintaining quality of life as opposed to life extension, are not clear. As there is no clear or "right" treatment choice, treatment decisions should be informed by patient preferences. However, currently in Singapore most patients choose dialysis and express decisional conflict and regret. Decision aids (DAs) together with values clarification methods (VCMs) can help patients choose a treatment that is concordant with their preferences and treatment goals. To help minimize decisional conflict among elderly ESKD patients, the first aim of this proposal is to adapt the current materials the investigators have developed (booklet and video) for elderly ESKD patients in a prior effort (NMRC/HSRG/0080/2017) into an interactive web-based tool called myKIDNEY. It will provide patients with tailored and relevant information based on their age and medical history, and help them identify and express their preferences via an interactive VCM. The second aim of the proposal is to test the benefits of counselling with myKIDNEY to standard renal counselling via a pre-post study design. The primary hypothesis is that patients and caregivers who receive counselling with myKIDNEY will report less decisional conflict compared to those who receive standard counselling. The investigators also hypothesize that fewer patients in the intervention arm will opt for dialysis, which is the more costly and invasive treatment option. If the proposed study shows evidence that the interactive tool improves decision-making quality in the local setting, this will result in a better patient experience. If fewer patients choose dialysis as per our hypothesis, this will also generate cost savings for the health system while at the same time allowing patients to choose their preferred treatment with lower chances of decisional conflict.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
208 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Pre-post study designPre-post study design
Masking:
Single (Participant)
Primary Purpose:
Health Services Research
Official Title:
End-Stage Kidney Disease Interactive Decision Aid for the Elderly (myKIDNEY)
Actual Study Start Date :
Jul 1, 2021
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Comparison arm

Patients and caregivers in this arm will receive existing counselling by trained counsellors.

Experimental: Intervention arm

Patients and caregivers in this arm will receive counselling with the newly developed web-based decision aid (myKIDNEY) by trained counsellors.

Other: myKIDNEY decision aid
Patients and caregivers will be counselled using myKIDNEY decision aid which includes a video. Patients will be asked to complete a values clarification exercise (VCE). If a caregiver is recruited without their patient, he/she will be asked to complete the VCE on patient's behalf (i.e., surrogate). At the end of VCE, the participant will be given real-time feedback on which treatment might be the best fit for the patient. With the patient's consent, this information will be shared with the treating physician who can then make recommendations based on the patient's preferences.

Outcome Measures

Primary Outcome Measures

  1. Decisional conflict scale (0 to 100; higher scores indicate higher decisional conflict) [1 hour]

    Difference in decisional conflict scale between the intervention and comparison arms

Secondary Outcome Measures

  1. Stated preferred treatment [Assessed after renal counselling (within 2 weeks after renal counselling)]

    Difference in the percentage of participants who choose a form of dialysis as the preferred treatment between the intervention and comparison arms

  2. Actual treatment choice [6 months after renal counselling]

    Difference in the percentage of participants who initiate dialysis based on the medical records at 6 months after the counselling between the intervention and comparison arms

  3. Actual treatment choice [12 months after renal counselling]

    Difference in the percentage of participants who initiate dialysis based on the medical records at 12 months after the counselling between the intervention and comparison arms

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria (patients):
  • Incident CKD Stage 5 patients with GFR<15ml/min

  • Aged 70 years or older-

  • Have not undergone counselling with a renal counsellor

  • Cognitively intact as determined by the Abbreviated Mental Test (AMT)

  • Speak and read English or Mandarin

Inclusion Criteria (caregivers):
  • Primary informal caregiver for an eligible patient (primarily involved in providing care, ensuring provision of care, and/or in making decisions regarding patient's care)

  • Aged 21 years and older

  • Direct relative of the patient

Exclusion Criteria:
  • Patients deemed to be mentally incompetent, and those not aware of their diagnosis will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National University Hospital Singapore Singapore
2 Singapore General Hospital Singapore Singapore

Sponsors and Collaborators

  • Duke-NUS Graduate Medical School
  • Singapore General Hospital
  • National University Hospital, Singapore

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Semra Ozdemir, Assistant Professor, Duke-NUS Graduate Medical School
ClinicalTrials.gov Identifier:
NCT05407896
Other Study ID Numbers:
  • 2020-SMF-0007
First Posted:
Jun 7, 2022
Last Update Posted:
Jun 7, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Semra Ozdemir, Assistant Professor, Duke-NUS Graduate Medical School
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2022